UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 75 filers reported holding UTAH MED PRODS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,788,677 | +56.3% | 116,524 | +66.2% | 0.10% | +50.0% |
Q1 2024 | $4,984,598 | +80.3% | 70,097 | +113.5% | 0.06% | +52.4% |
Q4 2023 | $2,764,522 | +18.7% | 32,825 | +21.2% | 0.04% | -6.7% |
Q3 2023 | $2,328,794 | +7.3% | 27,079 | +16.3% | 0.04% | +2.3% |
Q2 2023 | $2,169,696 | +6.5% | 23,280 | +8.3% | 0.04% | +2.3% |
Q1 2023 | $2,038,029 | +204.2% | 21,505 | +173.7% | 0.04% | +138.9% |
Q3 2022 | $670,000 | -1.6% | 7,858 | -0.9% | 0.02% | +5.9% |
Q2 2022 | $681,000 | -20.5% | 7,926 | -14.1% | 0.02% | -10.5% |
Q3 2021 | $857,000 | +4.1% | 9,226 | -4.7% | 0.02% | +5.6% |
Q2 2021 | $823,000 | +77.0% | 9,679 | +80.5% | 0.02% | +63.6% |
Q1 2021 | $465,000 | +97.0% | 5,362 | +117.3% | 0.01% | +120.0% |
Q2 2019 | $236,000 | -91.8% | 2,468 | -93.7% | 0.01% | -91.4% |
Q3 2017 | $2,870,000 | +1.3% | 39,022 | -0.3% | 0.06% | +28.9% |
Q2 2017 | $2,833,000 | +373.0% | 39,130 | +308.9% | 0.04% | +400.0% |
Q1 2016 | $599,000 | -27.9% | 9,570 | -32.6% | 0.01% | -25.0% |
Q4 2015 | $831,000 | – | 14,193 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Clean Yield Group | 26,010 | $2,305,000 | 1.00% |
Ranger Investment Management | 67,256 | $5,960,000 | 0.41% |
Hayden Royal, LLC | 11,709 | $660,739,000 | 0.37% |
AFFINITY INVESTMENT ADVISORS, LLC | 7,331 | $650,000 | 0.31% |
ISTHMUS PARTNERS, LLC | 13,561 | $1,202,000 | 0.30% |
RICE HALL JAMES & ASSOCIATES, LLC | 72,284 | $6,406,000 | 0.28% |
Cardinal Capital Management | 9,272 | $821,000 | 0.24% |
Ancora Advisors LLC | 52,873 | $4,686,000 | 0.20% |
GLOBEFLEX CAPITAL L P | 5,605 | $497,000 | 0.13% |
Penobscot Investment Management Company, Inc. | 4,000 | $354,000 | 0.07% |